Whistle-blower Ven-A-Care wins in Texas case against drug company

February 2, 2011
Los Angeles Times
By Andrew Zajac

The tiny south Florida pharmacy that built a profitable business blowing the whistle on drug companies that cheat the government has won a signal victory.

A Texas jury on Tuesday ordered two subsidiaries of Icelandic pharmaceuticals company Actavis to pay $170 million for overcharging the Texas Medicaid program. That means the whistle-blower — Ven-A-Care of the Florida Keys Inc. — is in line to receive millions in reward money for acting as the public's watchdog. Read more

Also In The News

Tell Us Your Thoughts

How do you feel about having to pay more than everyone else for your medication? Tell us your story. **By filling out this form you are giving RxRights permission to use your comments to help build support for safe, affordable drug importation.**